17 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
other countries and bulk purchasing. For example, in recent years, several states have formed prescription drug affordability boards (PDABs). Much … an affordability review. The effects of these efforts remain uncertain pending the outcomes of several federal lawsuits challenging state authority
6-K
EX-99
BLRX
Bioline Rx Ltd
12 Oct 23
BioLineRx Announces Closing of Exclusive License Agreement to Motixafortide
7:14am
immunotherapies and biologics for oncology. Toward the company’s ultimate goal of improving accessibility, affordability, and availability for patients
20-F/A
2014 FY
BLRX
Bioline Rx Ltd
23 Mar 15
Annual report (foreign) (amended)
12:00am
by the Health Care and Education Affordability Reconciliation Act (collectively, the PPACA), important legislation regarding health insurance which
424B5
qkqlr9x7fehofq
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
yrfkjl mpn
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
da9z1kl3k3ytz2l8eu
5 Mar 15
Current report (foreign)
12:00am
424B2
201o4to45lh8by8c
13 Jun 14
Prospectus for primary offering
12:00am
F-3
ytcnh77nfecg8on
30 May 14
Shelf registration (foreign)
12:00am
424B5
1oif0x69g
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
6c9yfnu
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
0wzlnlyy0fg qv30k
3 Mar 14
Current report (foreign)
12:00am
424B3
xih 730pok
8 Aug 13
Prospectus supplement
12:00am
424B5
u6tcc8
6 Feb 13
Prospectus supplement for primary offering
12:00am
- Prev
- 1
- Next